Radioreceptor assay for mouse prolactin (mPRL) was developed in the mo
use uterus. The specific binding of [I-125]-mPRL to the uterine prepar
ations was demonstrated and the binding was found to have a similar af
finity to that in the liver preparations. The specific PRL-binding to
the uterine preparations tended to increase after estrogen treatment,
while the differences among the three groups, diestrous intact, ovarie
ctomized, and ovariectomized and estrogen-treated mice, were statistic
ally not significant. Immunohistochemical staining of PRL revealed tha
t PRL immunoreactivity was preferentially localized in the myometrial
cells. Pituitary grafting into the uterus induced a high incidence of
adenomyosis associated with the increase in plasma PRL levels. Further
more, the PRL-binding activity in the uterus with adenomyosis was sign
ificantly higher than that in normal uterus. These results indicate th
at the elevation of PRL binding in the uterus, hyperprolactinemia, and
the development of adenomyosis are interrelated.